Efficacy of Teeth Whitening Product Offerings in Adults
Primary Purpose
Tooth Discoloration
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Hydrogen peroxide teeth whitening gel
GLO Brilliant Teeth Whitening Device
GLO Lit Teeth Whitening Device
GLO Science Professional Teeth Whitening Device
Sponsored by
About this trial
This is an interventional treatment trial for Tooth Discoloration focused on measuring Teeth whitening, Teeth bleaching, Tooth discoloration
Eligibility Criteria
Inclusion Criteria:
- Provide written informed consent to participate in the study.
- Be 18 to 65 years of age.
- Agree not to participate in any other oral/dental product studies during the trial.
- Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed.
- Agree to refrain from the use of any other teeth whitening products once assigned to a treatment group.
- Agree to refrain from the use of any oral care products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).
- Agree to return for all scheduled visits and follow study procedures.
- Be in good general health, as determined by the investigator/designee based on a review of the health history/update for participation in the study.
- Have at least 4 gradable maxillary anterior teeth ( canine to canine) with a Vita Shade average score of C2 or darker.
- Be willing to refrain from consuming stain-causing food and beverages (i.e., coffee, tea, red wine, berries, etc.) during the initial treatment duration (treatment period excluding the 4 week follow up).
- Be a current or recent non-smoker (no smoking for at least 3 months).
Exclusion Criteria:
- Are undergoing treatment for gingivitis, periodontitis, or caries.
- Presence of self-reported tooth sensitivity.
- Present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
- Have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth ( canine to canine) or mandibular anterior teeth.
- Have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
- Present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
- Have meaningful malocclusion that would impact treatment or ease of viewing/scoring maxillary anterior teeth.
- Have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypocalcification.
- Have any known allergies to over-the-counter oral hygiene/whitening products.
- Have any known allergies to the trial product ingredients.
- Are pregnant and/or breastfeeding.
- Are current smokers.
Sites / Locations
- Arizona School of Dentistry & Oral Health
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm Type
Experimental
Experimental
Experimental
Experimental
Experimental
Arm Label
GLO Science Professional Chairside Teeth Whitening
GLO Science Professional At-Home Teeth Whitening Device
GLO Brilliant At-Home Teeth Whitening Device
GLO Lit At-Home Teeth Whitening Device
GLO Lit Whitening GLO Vials
Arm Description
Outcomes
Primary Outcome Measures
Tooth whitening efficacy: tooth shade value
Change in tooth shade value as indicated by the digital VITA Easyshade V
Secondary Outcome Measures
Tooth whitening safety: presence/absence of adverse events
Post-treatment dentinal hypersensitivity and the presence/absence of adverse events
Full Information
NCT ID
NCT04124068
First Posted
October 10, 2019
Last Updated
February 4, 2020
Sponsor
Glo Science, Inc.
Collaborators
Arizona School of Dentistry & Oral Health, A. T. Still University
1. Study Identification
Unique Protocol Identification Number
NCT04124068
Brief Title
Efficacy of Teeth Whitening Product Offerings in Adults
Official Title
Efficacy of GLO Science Professional Teeth Whitening Product Offerings in Adults
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
September 1, 2019 (Actual)
Primary Completion Date
November 30, 2019 (Actual)
Study Completion Date
December 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Glo Science, Inc.
Collaborators
Arizona School of Dentistry & Oral Health, A. T. Still University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a 30 day randomized, parallel comparative trial where participants with tooth shade of C2 or darker will be assigned to one of five groups. The participants will be evaluated for the difference in tooth shade, as determined by the digital VITA Easyshade V (provided by GLO) before the respective whitening regimen (baseline), immediately following the treatment period, and at 30 days (~4 weeks) from end of the treatment intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tooth Discoloration
Keywords
Teeth whitening, Teeth bleaching, Tooth discoloration
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
75 (Actual)
8. Arms, Groups, and Interventions
Arm Title
GLO Science Professional Chairside Teeth Whitening
Arm Type
Experimental
Arm Title
GLO Science Professional At-Home Teeth Whitening Device
Arm Type
Experimental
Arm Title
GLO Brilliant At-Home Teeth Whitening Device
Arm Type
Experimental
Arm Title
GLO Lit At-Home Teeth Whitening Device
Arm Type
Experimental
Arm Title
GLO Lit Whitening GLO Vials
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Hydrogen peroxide teeth whitening gel
Intervention Description
Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%
Intervention Type
Device
Intervention Name(s)
GLO Brilliant Teeth Whitening Device
Intervention Description
Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
Intervention Type
Device
Intervention Name(s)
GLO Lit Teeth Whitening Device
Intervention Description
Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
Intervention Type
Device
Intervention Name(s)
GLO Science Professional Teeth Whitening Device
Intervention Description
Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
Primary Outcome Measure Information:
Title
Tooth whitening efficacy: tooth shade value
Description
Change in tooth shade value as indicated by the digital VITA Easyshade V
Time Frame
Immediately following treatment period (32 minutes, 5 days or 7 days), and after 30 days
Secondary Outcome Measure Information:
Title
Tooth whitening safety: presence/absence of adverse events
Description
Post-treatment dentinal hypersensitivity and the presence/absence of adverse events
Time Frame
Immediately following treatment period (32 minutes, 5 days or 7 days), and after 30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Provide written informed consent to participate in the study.
Be 18 to 65 years of age.
Agree not to participate in any other oral/dental product studies during the trial.
Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed.
Agree to refrain from the use of any other teeth whitening products once assigned to a treatment group.
Agree to refrain from the use of any oral care products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).
Agree to return for all scheduled visits and follow study procedures.
Be in good general health, as determined by the investigator/designee based on a review of the health history/update for participation in the study.
Have at least 4 gradable maxillary anterior teeth ( canine to canine) with a Vita Shade average score of C2 or darker.
Be willing to refrain from consuming stain-causing food and beverages (i.e., coffee, tea, red wine, berries, etc.) during the initial treatment duration (treatment period excluding the 4 week follow up).
Be a current or recent non-smoker (no smoking for at least 3 months).
Exclusion Criteria:
Are undergoing treatment for gingivitis, periodontitis, or caries.
Presence of self-reported tooth sensitivity.
Present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
Have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth ( canine to canine) or mandibular anterior teeth.
Have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
Present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
Have meaningful malocclusion that would impact treatment or ease of viewing/scoring maxillary anterior teeth.
Have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypocalcification.
Have any known allergies to over-the-counter oral hygiene/whitening products.
Have any known allergies to the trial product ingredients.
Are pregnant and/or breastfeeding.
Are current smokers.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ann Spolarich, RDH, PhD
Organizational Affiliation
Arizona School of Dentistry & Oral Health, A. T. Still University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Arizona School of Dentistry & Oral Health
City
Mesa
State/Province
Arizona
ZIP/Postal Code
85206
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Efficacy of Teeth Whitening Product Offerings in Adults
We'll reach out to this number within 24 hrs